Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (151-160 of 399) with videos related to

Pageof 40
Sort By:
Diabetes Care|September 13, 2013
Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunctionPer-Henrik Groop, Mark E Cooper, Vlado Perkovic, et al.
Gastroenterology|October 31, 2002
Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liverGeorgina Paizis, Mark E Cooper, Josefa M Schembri, et al.
Journal of Hypertension|February 18, 2005
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetesKarin A M Jandeleit-Dahm, Christos Tikellis, Christopher M Reid, et al.
Current Drug Targets|July 24, 2015
Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?Karly C Sourris, Henry Yao, George Jerums, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 24, 2004
The role of advanced glycation in reduced organic cation transport associated with experimental diabetesMerlin C Thomas, Christos Tikellis, Phillip Kantharidis, et al.
Journal of the American Society of Nephrology : JASN|September 20, 2001
Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathyDarren J Kelly, Richard E Gilbert, Alison J Cox, et al.
Journal of Hypertension|January 25, 2003
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrinBelinda J Davis, Zemin Cao, Marc de Gasparo, et al.
Clinical Science (London, England : 1979)|March 26, 2003
Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin systemMarkus Lassila, Belinda J Davis, Terri J Allen, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 12, 2002
Nephrin expression in the post-natal developing kidney in normotensive and hypertensive ratsFabrice Bonnet, Christos Tikellis, Hiroshi Kawachi, et al.
Lancet (London, England)|November 9, 2025
Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?Marcel H A Muskiet, Massimo Nardone, Patrick C N Rensen, et al.
Pageof 40

Showing results (151-160 of 399) with videos related to

Sort By:
Pageof 40
Diabetes Care|September 13, 2013
Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunctionPer-Henrik Groop, Mark E Cooper, Vlado Perkovic, et al.
Gastroenterology|October 31, 2002
Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liverGeorgina Paizis, Mark E Cooper, Josefa M Schembri, et al.
Journal of Hypertension|February 18, 2005
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetesKarin A M Jandeleit-Dahm, Christos Tikellis, Christopher M Reid, et al.
Current Drug Targets|July 24, 2015
Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?Karly C Sourris, Henry Yao, George Jerums, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 24, 2004
The role of advanced glycation in reduced organic cation transport associated with experimental diabetesMerlin C Thomas, Christos Tikellis, Phillip Kantharidis, et al.
Journal of the American Society of Nephrology : JASN|September 20, 2001
Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathyDarren J Kelly, Richard E Gilbert, Alison J Cox, et al.
Journal of Hypertension|January 25, 2003
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrinBelinda J Davis, Zemin Cao, Marc de Gasparo, et al.
Clinical Science (London, England : 1979)|March 26, 2003
Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin systemMarkus Lassila, Belinda J Davis, Terri J Allen, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 12, 2002
Nephrin expression in the post-natal developing kidney in normotensive and hypertensive ratsFabrice Bonnet, Christos Tikellis, Hiroshi Kawachi, et al.
Lancet (London, England)|November 9, 2025
Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?Marcel H A Muskiet, Massimo Nardone, Patrick C N Rensen, et al.
Pageof 40